Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H
- 30 October 2003
- journal article
- Published by Springer Nature in Leukemia
- Vol. 18 (1) , 57-62
- https://doi.org/10.1038/sj.leu.2403190
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupBritish Journal of Haematology, 2001
- Blood and marrow transplantation activity in Europe 1997Bone Marrow Transplantation, 1999
- Autologous peripheral blood stem cell transplantation for acute leukaemiasBest Practice & Research Clinical Haematology, 1999
- In vivo‘Purging’ of residual disease in CLL with Campath‐1HBritish Journal of Haematology, 1997
- Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemiaBritish Journal of Haematology, 1997
- Optimization of Peripheral Blood Stem Cell MobilizationThe International Journal of Cell Cloning, 1996
- Primary Structure of CD52Journal of Biological Chemistry, 1995
- Detection of monoclonality in low‐grade B‐cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma typeThe Journal of Pathology, 1993
- High-Dose Cytosine Arabinoside in Chronic Lymphocytic Leukemia: A Clinical and Pharmacologic AnalysisLeukemia & Lymphoma, 1993
- The CAMPATH‐1 antigen (CDw52)Tissue Antigens, 1990